Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
NeoGenomics downgraded to Outperform from Strong Buy at First Analysis » 05:21
01/23/20
01/23
05:21
01/23/20
05:21
NEO

NeoGenomics

$33.00 /

+0.63 (+1.95%)

First Analysis analyst…

First Analysis analyst Joseph Munda downgraded NeoGenomics to Outperform from Strong Buy with a price target of $35, up from $29. The analyst remains positive on the shares after meeting with management but downgraded the shares due to valuation. He feels the 41% appreciation since the company's Q3 earning report prices in much of the short-term potential. However, NeoGenomics remains one of Munda's favorite long-term names.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
Hot Stocks
NeoGenomics acquires Oncology Division assets of Human Longevity for $37M » 08:45
01/10/20
01/10
08:45
01/10/20
08:45
NEO

NeoGenomics

$29.63 /

+0.43 (+1.47%)

NeoGenomics announced…

NeoGenomics announced that the company has acquired the Oncology Division assets of Human Longevity for $37M. The transaction closed and was financed via available cash on hand. The Oncology Division of Human Longevity performs Next Generation Sequencing services for pharmaceutical customers. The Division generated approximately $10M in revenues in 2019 and ended the year with a backlog of approximately $15M of signed contracts. NeoGenomics expects acquired assets to be slightly dilutive to 2020 adjusted EBITDA before becoming accretive in 2021 and beyond.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Conference/Events
SVB Leerink life science analyst to hold an analyst/industry conference call » 10:25
12/16/19
12/16
10:25
12/16/19
10:25
NEO

NeoGenomics

$26.94 /

+0.52 (+1.97%)

Life Science Tools &…

Life Science Tools & Diagnostics Analyst Souda discusses liquid biopsy testing with NeoGenomics on an Analyst/Industry conference call to be held on December 16 at 11 am.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
SVB Leerink life science analyst to hold an analyst/industry conference call » 08:53
12/16/19
12/16
08:53
12/16/19
08:53
NEO

NeoGenomics

$26.42 /

-0.17 (-0.64%)

Life Science Tools &…

Life Science Tools & Diagnostics Analyst Souda discusses liquid biopsy testing with NeoGenomics on an Analyst/Industry conference call to be held on December 16 at 11 am.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
NeoGenomics management to meet with Leerink » 04:55
12/16/19
12/16
04:55
12/16/19
04:55
NEO

NeoGenomics

$26.42 /

-0.17 (-0.64%)

Meeting to be held in New…

Meeting to be held in New York on December 16 hosted by Leerink.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
NeoGenomics management to meet with Leerink » 11:54
12/13/19
12/13
11:54
12/13/19
11:54
NEO

NeoGenomics

$26.50 /

-0.09 (-0.34%)

Meeting to be held in New…

Meeting to be held in New York on December 16 hosted by Leerink.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Society for Immunotherapy of Cancer to hold annual meeting » 04:55
11/10/19
11/10
04:55
11/10/19
04:55
ALPN

Alpine Immune Sciences

$2.89 /

-0.03 (-1.03%)

, CUE

Cue Biopharma

$8.90 /

+0.39 (+4.58%)

, HTBX

Heat Biologics

$0.49 /

-0.0082 (-1.64%)

, AGEN

Agenus

$3.57 /

-0.12 (-3.25%)

, ALKS

Alkermes

$20.10 /

+0.38 (+1.93%)

, CRVS

Corvus Pharmaceuticals

$3.44 /

-0.35 (-9.23%)

, IOVA

Iovance Biotherapeutics

$23.63 /

+2.97 (+14.38%)

, THOR

Synthorx

$15.99 /

+1.86 (+13.16%)

, SURF

Surface Oncology

$1.74 /

+0.02 (+1.16%)

, TMO

Thermo Fisher

$294.51 /

+1.09 (+0.37%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$45.84 /

+0.385 (+0.85%)

, REGN

Regeneron

$341.94 /

+15.88 (+4.87%)

, PFE

Pfizer

$37.04 /

+0.12 (+0.33%)

, ILMN

Illumina

$293.23 /

-2.08 (-0.70%)

, INCY

Incyte

$84.98 /

+2.23 (+2.69%)

, AZN

AstraZeneca

$47.25 /

+0.46 (+0.98%)

, BMY

Bristol-Myers

$58.00 /

+0.41 (+0.71%)

, GILD

Gilead

$65.34 /

+1.36 (+2.13%)

, NWBO

Northwest Biotherapeutics

$0.00 /

+ (+0.00%)

, NVS

Novartis

$88.40 /

+1.34 (+1.54%)

, NEO

NeoGenomics

$22.69 /

+0.68 (+3.09%)

, MYGN

Myriad Genetics

$23.64 /

+0.12 (+0.51%)

, MRK

Merck

$83.59 /

+0.68 (+0.82%)

, FPRX

Five Prime

$3.90 /

+0.01 (+0.26%)

34th Annual Meeting of…

34th Annual Meeting of SITC will be held in National Harbor, Maryland on November 6-10.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Society for Immunotherapy of Cancer to hold annual meeting » 04:55
11/09/19
11/09
04:55
11/09/19
04:55
ALPN

Alpine Immune Sciences

$2.89 /

-0.03 (-1.03%)

, CUE

Cue Biopharma

$8.90 /

+0.39 (+4.58%)

, HTBX

Heat Biologics

$0.49 /

-0.0082 (-1.64%)

, AGEN

Agenus

$3.57 /

-0.12 (-3.25%)

, ALKS

Alkermes

$20.10 /

+0.38 (+1.93%)

, CRVS

Corvus Pharmaceuticals

$3.44 /

-0.35 (-9.23%)

, IOVA

Iovance Biotherapeutics

$23.63 /

+2.97 (+14.38%)

, THOR

Synthorx

$15.99 /

+1.86 (+13.16%)

, SURF

Surface Oncology

$1.74 /

+0.02 (+1.16%)

, TMO

Thermo Fisher

$294.51 /

+1.09 (+0.37%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$45.84 /

+0.385 (+0.85%)

, REGN

Regeneron

$341.94 /

+15.88 (+4.87%)

, PFE

Pfizer

$37.04 /

+0.12 (+0.33%)

, ILMN

Illumina

$293.23 /

-2.08 (-0.70%)

, INCY

Incyte

$84.98 /

+2.23 (+2.69%)

, AZN

AstraZeneca

$47.25 /

+0.46 (+0.98%)

, BMY

Bristol-Myers

$58.00 /

+0.41 (+0.71%)

, GILD

Gilead

$65.34 /

+1.36 (+2.13%)

, NWBO

Northwest Biotherapeutics

$0.00 /

+ (+0.00%)

, NVS

Novartis

$88.40 /

+1.34 (+1.54%)

, NEO

NeoGenomics

$22.69 /

+0.68 (+3.09%)

, MYGN

Myriad Genetics

$23.64 /

+0.12 (+0.51%)

, MRK

Merck

$83.59 /

+0.68 (+0.82%)

, FPRX

Five Prime

$3.90 /

+0.01 (+0.26%)

34th Annual Meeting of…

34th Annual Meeting of SITC will be held in National Harbor, Maryland on November 6-10.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Society for Immunotherapy of Cancer to hold annual meeting » 04:55
11/08/19
11/08
04:55
11/08/19
04:55
ALPN

Alpine Immune Sciences

$2.92 /

-0.08 (-2.67%)

, CUE

Cue Biopharma

$8.51 /

-0.07 (-0.82%)

, HTBX

Heat Biologics

$0.50 /

-0.0391 (-7.25%)

, AGEN

Agenus

$3.69 /

+0.035 (+0.96%)

, ALKS

Alkermes

$19.72 /

+0.04 (+0.20%)

, CRVS

Corvus Pharmaceuticals

$3.79 /

-0.1 (-2.57%)

, IOVA

Iovance Biotherapeutics

$20.66 /

-0.58 (-2.73%)

, THOR

Synthorx

$14.13 /

-0.39 (-2.69%)

, SURF

Surface Oncology

$1.72 /

+0.01 (+0.58%)

, TMO

Thermo Fisher

$293.42 /

-1.07 (-0.36%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$45.46 /

-0.705 (-1.53%)

, REGN

Regeneron

$326.06 /

+1.68 (+0.52%)

, PFE

Pfizer

$36.92 /

+0.03 (+0.08%)

, ILMN

Illumina

$295.31 /

-2.22 (-0.75%)

, INCY

Incyte

$82.75 /

-0.9 (-1.08%)

, AZN

AstraZeneca

$46.79 /

-0.54 (-1.14%)

, BMY

Bristol-Myers

$57.59 /

+0.61 (+1.07%)

, GILD

Gilead

$63.98 /

-1.43 (-2.19%)

, NWBO

Northwest Biotherapeutics

$0.00 /

+ (+0.00%)

, NVS

Novartis

$87.06 /

-0.38 (-0.43%)

, NEO

NeoGenomics

$22.01 /

-0.62 (-2.74%)

, MYGN

Myriad Genetics

$23.52 /

+0.34 (+1.47%)

, MRK

Merck

$82.91 /

-0.34 (-0.41%)

, FPRX

Five Prime

$3.89 /

-0.12 (-2.99%)

34th Annual Meeting of…

34th Annual Meeting of SITC will be held in National Harbor, Maryland on November 6-10.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Society for Immunotherapy of Cancer to hold annual meeting » 04:55
11/07/19
11/07
04:55
11/07/19
04:55
ALPN

Alpine Immune Sciences

$3.00 /

-0.23 (-7.12%)

, CUE

Cue Biopharma

$8.58 /

-0.27 (-3.05%)

, HTBX

Heat Biologics

$0.54 /

+0.0976 (+22.11%)

, AGEN

Agenus

$3.66 /

+0.425 (+13.16%)

, ALKS

Alkermes

$19.68 /

-0.48 (-2.38%)

, CRVS

Corvus Pharmaceuticals

$3.89 /

+0.01 (+0.26%)

, IOVA

Iovance Biotherapeutics

$21.24 /

-0.59 (-2.70%)

, THOR

Synthorx

$14.52 /

-1.76 (-10.81%)

, SURF

Surface Oncology

$1.71 /

+ (+0.00%)

, TMO

Thermo Fisher

$294.49 /

+1.93 (+0.66%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$46.16 /

+0.51 (+1.12%)

, REGN

Regeneron

$324.38 /

-8.46 (-2.54%)

, PFE

Pfizer

$37.61 /

+0.12 (+0.32%)

, ILMN

Illumina

$297.53 /

-3.19 (-1.06%)

, INCY

Incyte

$83.65 /

-0.4 (-0.48%)

, AZN

AstraZeneca

$47.33 /

+0.12 (+0.25%)

, BMY

Bristol-Myers

$56.98 /

+0.59 (+1.05%)

, GILD

Gilead

$65.41 /

+0.01 (+0.02%)

, NWBO

Northwest Biotherapeutics

$0.00 /

+ (+0.00%)

, NVS

Novartis

$87.44 /

+0.54 (+0.62%)

, NEO

NeoGenomics

$22.63 /

-0.85 (-3.62%)

, MYGN

Myriad Genetics

$23.18 /

+2.25 (+10.75%)

, MRK

Merck

$83.25 /

+0.32 (+0.39%)

, FPRX

Five Prime

$4.01 /

-0.11 (-2.67%)

34th Annual Meeting of…

34th Annual Meeting of SITC will be held in National Harbor, Maryland on November 6-10.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.